Logo image of CNTA

CENTESSA PHARMACEUTICALS-ADR (CNTA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CNTA - US1523091007 - ADR

29.03 USD
+0.05 (+0.17%)
Last: 11/28/2025, 8:21:11 PM
29.03 USD
0 (0%)
After Hours: 11/28/2025, 8:21:11 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CNTA revenue by date.CNTA revenue by date.
6.853M
-100.00%
16.847M3.14M
-81.36%
3.203M
2.01%
136.56M
4,163.50%
426.91M
212.62%
859.04M
101.22%
1.381B
60.76%
1.765B
27.81%
EBITDA
YoY % growth
CNTA ebitda by date.CNTA ebitda by date.
-153.6M
-1,371.26%
-212.13M
-38.11%
-170.473M
19.64%
-175.787M
-17.39%
-214.094M
-6.99%
-269.446M
-25.85%
-311.569M
-15.63%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CNTA ebit by date.CNTA ebit by date.
-153.63M
-1,371.55%
-212.26M
-38.16%
-171.283M
19.31%
-178.88M
-17.38%
-201.39M
-0.17%
-242.055M
-20.19%
-271.277M
-12.07%
-196.834M
27.44%
11.234M
105.71%
341.74M
2,942.02%
774.07M
126.51%
1.115B
44.04%
Operating Margin
CNTA operating margin by date.CNTA operating margin by date.
N/AN/A-2,499.39%N/A-1,195.41%-7,708.75%-8,469.47%-144.14%2.63%39.78%56.05%63.17%
EPS
YoY % growth
CNTA eps by date.CNTA eps by date.
N/A-2.31
-11.38%
-1.57
32.03%
-1.60
-10.19%
-1.39
19.45%
-1.66
-19.16%
-1.80
-8.68%
-1.16
35.70%
0.23
119.49%
2.17
858.05%
4.59
111.77%
6.38
38.95%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.39
32.29%
-0.41
-104.00%
-0.43
-13.63%
-0.44
-6.98%
-0.47
-19.48%
Revenue
Q2Q % growth

-100.00%
EBITDA
Q2Q % growth
-60.599M
17.71%
-65.172M
-113.26%
-70.968M
-30.91%
-72.274M
-36.08%
N/A
EBIT
Q2Q % growth
-57.665M
22.68%
-59.69M
-93.94%
-62.2M
-13.81%
-64.484M
-19.88%
-62.322M
-8.08%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.41
-10.81%
-0.40-0.01-3.48%
Q2 2025
Q2Q % growth
-0.38
5.00%
-0.35-0.03-7.99%
Q1 2025
Q2Q % growth
-0.20
47.37%
-0.380.1847.36%
Q4 2024
Q2Q % growth
-0.58
-52.63%
-0.46-0.12-27.41%
Q3 2024
Q2Q % growth
-0.37
7.50%
-0.420.0512.70%
Q2 2024
Q2Q % growth
-0.40
-53.85%
-0.39-0.01-1.54%
Q1 2024
Q2Q % growth
-0.38
28.30%
-0.430.0512.00%
Q4 2023
Q2Q % growth
-0.38
15.56%
-0.490.1122.59%
Q3 2023
Q2Q % growth
-0.40
29.82%
-0.530.1323.96%
Q2 2023
Q2Q % growth
-0.26
62.32%
-0.500.2448.23%
Q1 2023
Q2Q % growth
-0.53
11.67%
-0.42-0.11-25.91%
Q4 2022
Q2Q % growth
-0.45
33.82%
-0.490.048.28%
Q3 2022
Q2Q % growth
-0.57
-26.67%
-0.580.011.09%
Q2 2022
Q2Q % growth
-0.69
-6.15%
-0.58-0.11-18.68%
Q1 2022
Q2Q % growth
-0.60
19.42%
-0.710.1115.56%
Q4 2021
Q2Q % growth
-0.68 -0.61-0.07-11.73%
Q3 2021
Q2Q % growth
-0.45 -0.560.1120.27%
Q2 2021
Q2Q % growth
-0.65 -0.680.034.17%
CNTA Yearly EPS VS EstimatesCNTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
918K-918K-100.00%
Q4 2024
Q2Q % growth

-100.00%
%
CNTA Yearly Revenue VS EstimatesCNTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS3.56% 6.33% 0.94% 1.16%
Revenue-100% N/A 10.11% 10.11%